8MAY 2024For quite some time now, Genetic Engineering has been promising to reshape the Health Care landscape and to help humanity overcome diseases and avoid health problems by providing us with the tools to manipulate two of the pillars of the evolution: random mutation and natural selection. These promises have become a reality and the understanding and knowledge of how genes function have given place to several treatments/drugs to fight orphan diseases, cancer, and other chronic conditions. All these treatments can be summarized under one name: Gene Therapy.Although the option of Gene Therapy is a reality, its novelty, along with the limited number of manufacturers developing these treatments and the small number of patients with low incidence diseases that can be treated with these therapies, has introduced several challenges into the health care system worldwide. Manufacturers, health care providers and the insurance/reinsurance industry must collaborate to SOLUTIONS FOR FINANCING AND REIMBURSEMENT OF GENE THERAPIESBy Blanca Diaz, Vice President Claims, Risk Strategies CompanyBlanca DiazOPINIONIN MY
< Page 7 | Page 9 >